{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:17:24Z","timestamp":1790749044265,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000080","name":"Anesthesia Patient Safety Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bja.2020.07.042","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T01:37:48Z","timestamp":1598492268000},"page":"995-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A multi-dimensional analysis of genotype\u2013phenotype discordance in malignant hyperthermia susceptibility"],"prefix":"10.1016","volume":"125","author":[{"given":"Carlos A.","family":"Ibarra Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kraeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zvaritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Biesecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van Petegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2020.07.042_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2020.07.042_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A\u00a0clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.07.042_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","article-title":"Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands","volume":"118","author":"Riazi","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.07.042_bib4","first-page":"511","article-title":"Standardization of the caffeine halothane muscle contracture test","volume":"69","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2020.07.042_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.07.042_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2220\/biomedres.4.83","article-title":"Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia","volume":"4","author":"Endo","year":"1983","journal-title":"Biomed Res"},{"key":"10.1016\/j.bja.2020.07.042_bib7","series-title":"Malignant hyperthermia","first-page":"279","article-title":"Diagnosis of malignant hyperthermia in Japan by the skinned fibre test","author":"Kikuchi","year":"1987"},{"key":"10.1016\/j.bja.2020.07.042_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","article-title":"The sensitivity and specificity of the caffeine\u2013halothane contracture test: a report from the North American malignant hyperthermia registry. The North American malignant hyperthermia registry of MHAUS","volume":"88","author":"Allen","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.07.042_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In\u00a0vitro contracture test for the diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH, and unrelated low-risk subjects","volume":"41","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2020.07.042_bib10","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.07.042_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant hyperthermia in the post-genomics era: new perspectives on an old concept","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.07.042_bib12","series-title":"Malignant hyperthermia susceptibility","first-page":"1993","author":"Rosenberg","year":"2003"},{"key":"10.1016\/j.bja.2020.07.042_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000542-199307000-00003","article-title":"False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia","volume":"79","author":"Isaacs","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2020.07.042_bib14","first-page":"1334","article-title":"Discordance, in a malignant hyperthermia pedigree, between in\u00a0vitro contracture-test phenotypes and haplotypes for the MHS 1 region on chromosome 19q12\u201313.2, comprising the C1840T transition in the RYR1 gene","volume":"56","author":"Deufel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2020.07.042_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bja.2020.07.042_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2020.07.042_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bja.2018.08.009","article-title":"Abnormal calcium signalling and the caffeine\u2013halothane contracture test","volume":"122","author":"Figueroa","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.07.042_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2016.08.075","article-title":"Structural basis for gating and activation of RyR1","volume":"167","author":"des Georges","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bja.2020.07.042_bib19","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/ncomms2501","article-title":"Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface","volume":"4","author":"Kimlicka","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2020.07.042_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature09471","article-title":"The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule","volume":"468","author":"Tung","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bja.2020.07.042_bib21","series-title":"The PyMOL molecular graphics system","author":"Schrodinger","year":"2015"},{"key":"10.1016\/j.bja.2020.07.042_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.bja.2020.07.042_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12630-011-9494-6","article-title":"Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population","volume":"58","author":"Kraeva","year":"2011","journal-title":"Can J Anesth"},{"key":"10.1016\/j.bja.2020.07.042_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-genet-120417-031311","article-title":"Calcium channelopathies: structural insights into disorders of the muscle excitation\u2013contraction complex","volume":"52","author":"Pancaroglu","year":"2018","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.bja.2020.07.042_bib25","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.str.2013.06.012","article-title":"The cardiac ryanodine receptor N-terminal region contains an anion binding site that is targeted by disease mutations","volume":"21","author":"Kimlicka","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bja.2020.07.042_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/0310057X1704500512","article-title":"Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an update","volume":"45","author":"Frei","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2020.07.042_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2020.07.042_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-019-0688-9","article-title":"Is 'likely pathogenic' really 90% likely? Reclassification data in ClinVar","volume":"11","author":"Harrison","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.bja.2020.07.042_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng0993-51","article-title":"Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia","volume":"5","author":"Quane","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.bja.2020.07.042_bib30","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease","volume":"272","author":"Tong","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2020.07.042_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.274.2.693","article-title":"Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels","volume":"274","author":"Tong","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2020.07.042_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.118.3.277","article-title":"Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor","volume":"118","author":"Avila","year":"2001","journal-title":"J\u00a0Gen Physiol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091220306334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091220306334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:58:49Z","timestamp":1757789929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091220306334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0007091220306334"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2020.07.042","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-dimensional analysis of genotype\u2013phenotype discordance in malignant hyperthermia susceptibility","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2020.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2020.08.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}